Stern, E K <br/><br/>
Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.  [electronic resource] 

 -  Neurogastroenterology and motility  02 2018 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2982 
<br/><br/><label>Standard No.: </label>10.1111/nmo.13247  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Case-Control Studies<br/>Endoscopy, Gastrointestinal<br/>Esophageal pH Monitoring<br/>Female<br/>Gastroesophageal Reflux--drug therapy<br/>Humans<br/>Male<br/>Manometry<br/>Middle Aged<br/>Proton Pump Inhibitors--therapeutic use<br/>Retrospective Studies<br/>Scleroderma, Systemic--complications<br/>Treatment Outcome